Also advancing an amylin candidate is AstraZeneca, which is positioning its AZD6234 as a potential alternative or complement to GLP-1 therapies
One ml of this B-Complex 100 Injection contains 100 mg of thiamine, 5 mg of riboflavin, 2 mg of pyridoxine, 2 mg of pantothenic acid, and 100 mg of niacin
Human clinical research remains early stage, with small pilot studies exploring its effects on exercise performance, insulin sensitivity, and metabolic biomarkers rather than obesity endpoints
In this process, it becomes oxidized
Kidney disease: High B12 levels can result from damage to cells, which releases substances like hemoglobin and B vitamins into the blood